Correction to Synthetic Approaches to the New Drugs Approved During 2015

Synthetic Approaches to the New Drugs Approved During 2024.

Journal of medicinal chemistry·2026

Synthetic Approaches to the New Drugs Approved during 2023.

Journal of medicinal chemistry·2025

Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease.

PloS one·2024

Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1.

Journal of medicinal chemistry·2024

Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease.

Journal of medicinal chemistry·2024

Synthetic Approaches to the New Drugs Approved During 2022.

Journal of medicinal chemistry·2024

A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.

Journal of medicinal chemistry·2026

From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis.

Journal of medicinal chemistry·2026

Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria.

Journal of medicinal chemistry·2026

Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.

Journal of medicinal chemistry·2026

Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.

Journal of medicinal chemistry·2026

Synthesis, Biological Evaluation, and Biodistribution of Xinyne, a Novel Quinazoline-carbazole N-methylamine Anticancer Agent Used in Mice Xenograft Models.

Journal of medicinal chemistry·2026

Bergamottin: a multitarget natural furanocoumarin with promising anticancer potential.

Translational cancer research·2026

Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.

Molecular therapy. Nucleic acids·2026

AaSnRK2.6 interacts with AaORA to positively regulate artemisinin biosynthesis in Artemisia annua.

Horticulture research·2026

Intramolecularly quenched fluorogens enable multispectral activation with a fluorescein-targeting single-chain variable fragment.

Organic & biomolecular chemistry·2026

Phosphorylated Analogs of Paracetamol and Their Anti-Inflammatory Potential.

ChemMedChem·2026

Synthesis and Assessment of the Enantioselectivity in Antitumor Activity of a Library of Novel Chiral Flavone Derivatives.

ChemMedChem·2026

Related Experiment Videos

Correction to Synthetic Approaches to the New Drugs Approved During 2015

Related Concept Videos

Synthetic Approaches to the New Drugs Approved During 2024.

Synthetic Approaches to the New Drugs Approved during 2023.

Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease.

Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1.

Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease.

Synthetic Approaches to the New Drugs Approved During 2022.

A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.

From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis.

Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria.

Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.

Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.

Synthesis, Biological Evaluation, and Biodistribution of Xinyne, a Novel Quinazoline-carbazole N-methylamine Anticancer Agent Used in Mice Xenograft Models.

Bergamottin: a multitarget natural furanocoumarin with promising anticancer potential.

Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.

AaSnRK2.6 interacts with AaORA to positively regulate artemisinin biosynthesis in Artemisia annua.

Intramolecularly quenched fluorogens enable multispectral activation with a fluorescein-targeting single-chain variable fragment.

Phosphorylated Analogs of Paracetamol and Their Anti-Inflammatory Potential.

Synthesis and Assessment of the Enantioselectivity in Antitumor Activity of a Library of Novel Chiral Flavone Derivatives.

Related Experiment Videos

Correction to Synthetic Approaches to the New Drugs Approved During 2015

Related Concept Videos

Related Articles